Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Gordon C. Jayson

1-50 of 173 results

View this query on the Wikidata Query Service
Ovarian cancer

scholarly article
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

scientific article published in June 2003
Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI.

scientific article published in November 2006
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.

scientific article
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.

scientific article published on 19 May 2015
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.

scientific article published on May 2005
Antiangiogenic therapy in oncology: current status and future directions

scientific article published on 4 February 2016
Imaging biomarker roadmap for cancer studies

scientific article
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

scientific article
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

scientific article
Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies

scientific article published on 14 February 2012
Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging.

scientific article published on June 2007
Intra-tumoural microvessel density in human solid tumours.

scientific article
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors

scientific article published on 15 December 2009
Randomized phase II placebo-controlled trial of maintenance therapy using the oral triple angiokinase inhibitor BIBF 1120 after chemotherapy for relapsed ovarian cancer.

scientific article
Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imaging

scientific article
Antiangiogenic therapy--evolving view based on clinical trial results

scientific article published on 14 February 2012
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.

scientific article
Heparan sulfate proteoglycans and cancer.

scientific article
Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume.

scientific article
Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors.

scientific article published on April 2007
Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives

scientific article published on August 2008
Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro

scientific article published in January 1998
Molecular phenotyping of a UK population: defining the human serum metabolome

scientific article
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer.

scientific article
Preliminary study of oxygen-enhanced longitudinal relaxation in MRI: a potential novel biomarker of oxygenation changes in solid tumors

scientific article published on 26 March 2009
Social support, anxiety and depression after chemotherapy for ovarian cancer: a prospective study

scientific article published in November 2004
Platelet-derived growth factor receptor (PDGFR): a target for anticancer therapeutics.

scientific article
Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma

scientific article published in March 2003
Molecular imaging of antiangiogenic agents.

scientific article
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

scientific article published on 22 March 2016
Alpha-v integrins as therapeutic targets in oncology.

scientific article published on October 2007
A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion.

scientific article
Carcinomatous meningitis in solid tumours

scientific article
Targeted anti-vascular therapies for ovarian cancer: current evidence

scientific article
Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy.

scientific article
Quantitative angiogenesis assays in vivo--a review.

scientific article published in January 2004
Comparison of normal tissue R1 and R*2 modulation by oxygen and carbogen

scientific article published in January 2009
Organ-specific effects of oxygen and carbogen gas inhalation on tissue longitudinal relaxation times

scientific article published in September 2007
Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant

scientific article published on 01 December 1994
Antiangiogenic drugs in ovarian cancer.

scientific article
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials.

scientific article published in January 2003
Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer

scientific article
Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor.

scientific article
Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.

scientific article published on July 2006
Chemotherapy for ovarian cancer--a consensus statement on standard practice.

scientific article published on December 1998
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors

scientific article
Carcinosarcoma of the ovary.

scientific article
Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer

scientific article published on 01 November 2007
Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer

scientific article published on September 2005

Paulina is supported by:

About Paulina

Help